Efficacy of indomethacin in in the prevention of premature ovulation in in vitro fertilisation treatment in a with a GnRH-antagonist modified natural cycle.

Trial Profile

Efficacy of indomethacin in in the prevention of premature ovulation in in vitro fertilisation treatment in a with a GnRH-antagonist modified natural cycle.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2011

At a glance

  • Drugs Indometacin (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
    • 02 May 2009 Additional lead trial centre University Medical Center Groningen, Department of Obstetrics and Gynaecology reported by Netherlands Trial Register.
    • 09 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top